An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk (Q36615906)

15 August 2017

0 references

An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk (English)

1 reference

15 August 2017

1 reference

S A Lee

1

1 reference

15 August 2017

R K Ross

series ordinal

2

1 reference

15 August 2017

M C Pike

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

92

1 reference

15 August 2017

11

1 reference

15 August 2017

2049-2058

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602617

15 August 2017

0 references

cites work

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Postmenopausal estrogen and progestin use in relation to breast cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Bias in meta-analysis detected by a simple, graphical test

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Operating characteristics of a rank correlation test for publication bias

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Analysis of data from multiclinic trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Meta-analysis in clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Progestational potency of oral contraceptives

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Hormone replacement therapy regimens and breast cancer risk(1).

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Bias in breast cancer analyses due to error in age at menopause.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361783

Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada

21 October 2018

1 reference

12 December 2020

The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette

1 reference

12 December 2020

Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

1 reference

12 December 2020

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

1 reference

12 December 2020

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1 reference

12 December 2020

Menopausal hormones and breast cancer in a biracial population

1 reference

12 December 2020

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

12 December 2020

Hormone replacement therapy in relation to breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602617

1 reference

15 August 2017

1 reference

15 August 2017

1 reference